Back to Market Feed

STELARA 90 MG/ML SYRINGE

ustekinumab
$29794.5000per ML

Strength

90 mg/mL

NDC

57894006103

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/2/2026

Active Ingredients

USTEKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125261

On Market Since

9/25/2009

Pharmacological Classes

Interleukin-12 Antagonist
Interleukin-12 Antagonists
Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+5.5%

3Y

+16.5%

5Y

+27.6%

All

+130.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

TREMFYA 200 MG/2 ML PEN
Brand
57894065102•Janssen Biotech, Inc.
$7349.6703
per ML
TREMFYA 100 MG/ML ONE-PRESS
Brand
57894064011•Janssen Biotech, Inc.
$14766.3280
per ML
TREMFYA 100 MG/ML SYRINGE
Brand
57894064001•Janssen Biotech, Inc.
$14769.7353
per ML
SKYRIZI 150 MG/ML PEN
Brand
00074210001•AbbVie Inc.
$22807.6858
per ML
SKYRIZI 150 MG/ML SYRINGE
Brand
00074105001•AbbVie Inc.
$22942.3716
per ML